Major Pharmaceuticals and Cardinal Health recall hypothyroidism medication due to sub-potent active ingredient

Major Pharmaceuticals and Cardinal Health have initiated a nationwide recall of hypothyroidism medication following internal testing that revealed lower-than-specified concentrations of the active ingredient. The recall addresses potential therapeutic failure for patients relying on consistent dosing, though the specific scope of the affected batches remains to be fully detailed.